FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

SPOTLIGHT: Fledgling biotech hunts for cash


The backers of a fledgling northern Virginia biotech named Cary Pharmaceuticals has been out beating the bushes for $14 million in new investment funds to carry the company into the clinic. So far, about $2.6 million has been raised from family, friends, a federal grant and a manufacturing partner. Report

More stories about pharmaceuticals  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 29 + 42?
To combat spam, please solve the math question above.